Center for Scientific Review; Notice of Closed Meetings, 36606-36607 [2023-11870]
Download as PDF
<![CDATA[
36606
Federal Register / Vol. 88, No. 107 / Monday, June 5, 2023 / Notices
Agenda: To review and evaluate grant
applications.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 903 South 4th Street, Room 31118F,
Hamilton, MT 59840 (Virtual Meeting).
Contact Person: Kristin L. McNally, Ph.D.,
Scientific Review Officer, Scientific Review
Program, National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 903 South 4th Street, Room 31118F,
Hamilton, MT 59840 mcnallyk@
niaid.nih.gov.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; Therapeutics for
Eliminating Hepatitis B Virus cccDNA (R21/
R33 Clinical Trial Not Allowed).
Date: June 30, 2023.
Time: 10:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3E70A,
Rockville, MD 20892 (Virtual Meeting).
Contact Person: Soheyla Saadi, Ph.D.,
Scientific Review Officer, Scientific Review
Program, National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3E70A,
Rockville, MD 20892, (240) 669–5178,
saadisoh@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: May 31, 2023.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2023–11847 Filed 6–2–23; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
ddrumheller on DSK120RN23PROD with NOTICES1
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Oncology 2—
Translational Clinical Integrated Review
VerDate Sep<11>2014
17:59 Jun 02, 2023
Jkt 259001
Group; Cellular Immunotherapy of Cancer
Study Section.
Date: June 26–27, 2023.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency, Bethesda, One
Bethesda Metro Center, 7400 Wisconsin Ave.,
Bethesda, MD 20814.
Contact Person: Shahana Majid, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, (301) 867–5309, shahana.majid@
nih.gov.
Name of Committee: Oncology 2—
Translational Clinical Integrated Review
Group; Clinical Oncology Study Section.
Date: June 26–27, 2023.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Laura Asnaghi, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institute of
Health, 6701 Rockville Drive Room 6200,
MSC 7804, Bethesda, MD 20892, (301) 443–
1196, laura.asnaghi@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Biobehavioral Processes.
Date: June 26–27, 2023.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892, (Virtual Meeting).
Contact Person: Jeanne M. McCaffery,
Scientific Review Officer, Center for
Scientific Review, 6701 Rockledge Drive,
Bethesda, MD 20892, 301–594–3854,
jeanne.mccaffery@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Drug Discovery and Development.
Date: June 26–27, 2023.
Time: 10:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Sergei Ruvinov, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4158,
MSC 7806, Bethesda, MD 20892, 301–435–
1180, ruvinser@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Innate and Adaptive Immunity to
Pathogens.
Date: June 26, 2023.
Time: 1:00 p.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Shiv A. Prasad, Ph.D.,
Scientific Review Officer, Center for
PO 00000
Frm 00081
Fmt 4703
Sfmt 4703
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5220,
MSC 7852, Bethesda, MD 20892, 301–443–
5779, prasads@csr.nih.gov.
Name of Committee: Oncology 1—Basic
Translational Integrated Review Group;
Biochemical and Cellular Oncogenesis Study
Section.
Date: June 27–28, 2023.
Time: 9:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Jian Cao, MD, Scientific
Review Officer, Center for Scientific Review,
National Institutes of Health, 6701 Rockledge
Drive, Bethesda, MD 20892, (301) 827–5902,
caojn@csr.nih.gov.
Name of Committee: Genes, Genomes, and
Genetics Integrated Review Group;
Therapeutic Approaches to Genetic Diseases
Study Section.
Date: June 27–28, 2023.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Karobi Moitra, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, (301) 480–6893, karobi.moitra@
nih.gov.
Name of Committee: Musculoskeletal, Oral
and Skin Sciences Integrated Review Group;
Skeletal Muscle and Exercise Physiology
Study Section.
Date: June 27–28, 2023.
Time: 9:00 a.m. to 7:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Richard Ingraham, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4116,
MSC 7814, Bethesda, MD 20892, (301) 496–
8551, ingrahamrh@mail.nih.gov.
Name of Committee: Biology of
Development and Aging Integrated Review
Group; Advancing Therapeutics A Study
Section.
Date: June 27–28, 2023.
Time: 9:30 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Maureen Shuh, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, (301) 480–4097, maureen.shuh@
nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Interspecies
Microbial Interactions and Infections.
Date: June 27, 2023.
E:\FR\FM\05JNN1.SGM
05JNN1
Federal Register / Vol. 88, No. 107 / Monday, June 5, 2023 / Notices
Time: 10:00 a.m. to 9:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Subhamoy Pal, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, 6701 Rockledge Drive,
Bethesda, MD 20892, 301–594–0926,
subhamoy.pal@nih.gov.
Name of Committee: Endocrinology,
Metabolism, Nutrition and Reproductive
Sciences Integrated Review Group;
Pathophysiology of Obesity and Metabolic
Disease Study Section.
Date: June 27–28, 2023.
Time: 10:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Heather Marie Brockway,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 813H,
Bethesda, MD 20892, (301) 594–5228,
brockwayhm@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: May 31, 2023.
Victoria E. Townsend,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2023–11870 Filed 6–2–23; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HOMELAND
SECURITY
Coast Guard
[Docket No. USCG–2021–0345]
Port Access Route Study: The Pacific
Coast From Washington to California
Coast Guard, DHS.
ACTION: Notice of availability of study.
AGENCY:
The Coast Guard announces
the availability of the study results of
the Pacific Coast Port Access Route
Study. This study evaluated safe access
routes for the movement of vessel traffic
proceeding to or from ports or places
along the western seaboard of the
United States. As a result of the study
data and public input, the Coast Guard
recommends the establishment of
voluntary shipping fairways (‘‘fairway’’)
for coastwise and nearshore vessel
traffic to promote the safe, unobstructed
navigation of vessels in the study area.
FOR FURTHER INFORMATION CONTACT: For
information about this document call or
ddrumheller on DSK120RN23PROD with NOTICES1
SUMMARY:
VerDate Sep<11>2014
17:59 Jun 02, 2023
Jkt 259001
email LCDR Sara Conrad, Coast Guard
Pacific Area (PAC–54), U.S. Coast
Guard; telephone (510) 437–3813, email
Sara.E.Conrad@uscg.mil or Mr. Tyrone
Conner, Eleventh Coast Guard District
(dpw), U.S. Coast Guard; telephone
(510) 437–2968, email
Tyrone.L.Conner@uscg.mil or Mr. John
Moriarty, Thirteenth Coast Guard
District (dpw), U.S. Coast Guard;
telephone (206) 220–7274, email
John.F.Moriarty@uscg.mil.
SUPPLEMENTARY INFORMATION:
Background
The Ports and Waterways Safety Act,
(PWSA)(46 U.S.C. 70003(c)(1)),
authorizes the Commandant of the Coast
Guard to designate necessary fairways
and traffic separations schemes (TSSs)
to provide safe access routes for vessels
proceeding to and from United States
ports. The designation of fairways and
TSSs recognizes the paramount right of
navigation over all other uses in the
designated areas.
Before establishing or adjusting
fairways, 46 U.S.C. 70003(c)(1) requires
the Coast Guard to study potential
traffic density and assess the need for
safe access routes for vessels. During
this process, the Coast Guard considers
the views of the maritime community,
environmental groups, and other
stakeholders to reconcile the need for
safe access routes with reasonable
waterway uses. See 46 U.S.C.
70003(c)(3).
On July 28, 2021, the Coast Guard
announced that the Coast Guard Pacific
Area Command would conduct a Pacific
Coast Port Access Route Study (PAC–
PARS). 86 FR 40791. The study area
encompassed all vessel traffic patterns
approaching and departing major ports
along the west coast to include all
current Traffic Separation Schemes and
vessel maneuvering along the Pacific
Coast from Washington to California
and all federal navigable waters out to
the EEZ. The PAC–PARS was focused
on vessel traffic and navigation
mitigation techniques to improve and
support safe navigation transits within
the major Pacific Coast Ports and the
United States EEZ.
The PAC–PARS aimed to enhance
navigational safety by examining
existing shipping routes and waterway
uses and, to the extent practicable,
reconciling the paramount right of
navigation within designated port
access routes with other waterway uses
such as the development of aquaculture
farms, offshore renewable energy,
commercial space ports/re-entry sites,
marine sanctuaries, ports supporting
Panamax vessels, potential LNG ports
PO 00000
Frm 00082
Fmt 4703
Sfmt 4703
36607
and additional commercial vessel
traffic.
On August 26, 2022, the Coast Guard
published a draft study containing
recommended routing measures and
requested public comments. After
examining stakeholder responses to the
draft recommendations, analyzing
current and historical vessel traffic,
fishing vessel information, agency and
stakeholder experience in vessel traffic
management, navigation, ship handling,
and effects of weather, the study
determined that there is a need to
establish voluntary fairways for
coastwise and nearshore vessel traffic to
promote safety of navigation in the
study area. As part of the PAC–PARS
Final Report, which is available for
public review in this docket, charts of
the recommended fairways are included
as Appendices I, II, and III. Examples of
public notice and outreach documents
are included in Appendices IV–X. Two
vessel traffic analyses, for coastal waters
and port approaches, are included as
Enclosures 1 and 2, respectively. Earlier
Federal Register announcements
associated with this effort are included
as Enclosures 3–5. Enclosure 6 contains
the Public Comments adjudication
included in the Draft Study. Finally, the
three recommendation memorandums
from each Coast Guard command
involved in this study are provided in
Enclosures 7, 8, and 9.
The Final Study, appendices, and
enclosures can also be found at the
Coast Guard Navigation Center website
Port Access Route Studies | Navigation
Center (uscg.gov).
This notice is issued under authority
of 46 U.S.C. 70003(c)(1).
Dated: May 25, 2023.
A.J. Tiongson,
Vice Admiral, U.S. Coast Guard, Commander,
Pacific Area.
[FR Doc. 2023–11878 Filed 6–2–23; 8:45 am]
BILLING CODE 9110–04–P
DEPARTMENT OF HOMELAND
SECURITY
Federal Emergency Management
Agency
[Docket ID FEMA–2023–0002; Internal
Agency Docket No. FEMA–B–2343]
Proposed Flood Hazard
Determinations
Federal Emergency
Management Agency, Department of
Homeland Security.
ACTION: Notice.
AGENCY:
Comments are requested on
proposed flood hazard determinations,
SUMMARY:
E:\FR\FM\05JNN1.SGM
05JNN1
]]>Agencies
[Federal Register Volume 88, Number 107 (Monday, June 5, 2023)]
[Notices]
[Pages 36606-36607]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-11870]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Oncology 2--Translational Clinical Integrated
Review Group; Cellular Immunotherapy of Cancer Study Section.
Date: June 26-27, 2023.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Hyatt Regency, Bethesda, One Bethesda Metro Center, 7400
Wisconsin Ave., Bethesda, MD 20814.
Contact Person: Shahana Majid, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892, (301) 867-5309,
[email protected].
Name of Committee: Oncology 2--Translational Clinical Integrated
Review Group; Clinical Oncology Study Section.
Date: June 26-27, 2023.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Laura Asnaghi, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institute of Health, 6701
Rockville Drive Room 6200, MSC 7804, Bethesda, MD 20892, (301) 443-
1196, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Small Business: Biobehavioral Processes.
Date: June 26-27, 2023.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892, (Virtual Meeting).
Contact Person: Jeanne M. McCaffery, Scientific Review Officer,
Center for Scientific Review, 6701 Rockledge Drive, Bethesda, MD
20892, 301-594-3854, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Small Business: Drug Discovery and Development.
Date: June 26-27, 2023.
Time: 10:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Sergei Ruvinov, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4158, MSC 7806, Bethesda, MD
20892, 301-435-1180, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Innate and Adaptive Immunity to Pathogens.
Date: June 26, 2023.
Time: 1:00 p.m. to 7:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Shiv A. Prasad, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5220, MSC 7852, Bethesda, MD
20892, 301-443-5779, [email protected].
Name of Committee: Oncology 1--Basic Translational Integrated
Review Group; Biochemical and Cellular Oncogenesis Study Section.
Date: June 27-28, 2023.
Time: 9:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Jian Cao, MD, Scientific Review Officer, Center
for Scientific Review, National Institutes of Health, 6701 Rockledge
Drive, Bethesda, MD 20892, (301) 827-5902, [email protected].
Name of Committee: Genes, Genomes, and Genetics Integrated
Review Group; Therapeutic Approaches to Genetic Diseases Study
Section.
Date: June 27-28, 2023.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Karobi Moitra, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892, (301) 480-6893,
[email protected].
Name of Committee: Musculoskeletal, Oral and Skin Sciences
Integrated Review Group; Skeletal Muscle and Exercise Physiology
Study Section.
Date: June 27-28, 2023.
Time: 9:00 a.m. to 7:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Richard Ingraham, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4116, MSC 7814, Bethesda, MD
20892, (301) 496-8551, [email protected].
Name of Committee: Biology of Development and Aging Integrated
Review Group; Advancing Therapeutics A Study Section.
Date: June 27-28, 2023.
Time: 9:30 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Maureen Shuh, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892, (301) 480-4097,
[email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Interspecies Microbial Interactions and Infections.
Date: June 27, 2023.
[[Page 36607]]
Time: 10:00 a.m. to 9:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Subhamoy Pal, Ph.D., Scientific Review Officer,
Center for Scientific Review, 6701 Rockledge Drive, Bethesda, MD
20892, 301-594-0926, [email protected].
Name of Committee: Endocrinology, Metabolism, Nutrition and
Reproductive Sciences Integrated Review Group; Pathophysiology of
Obesity and Metabolic Disease Study Section.
Date: June 27-28, 2023.
Time: 10:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Heather Marie Brockway, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 813H, Bethesda, MD 20892, (301)
594-5228, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: May 31, 2023.
Victoria E. Townsend,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2023-11870 Filed 6-2-23; 8:45 am]
BILLING CODE 4140-01-P
